Antiphospholipid antibodies in patients with lupus nephritis

Renal Failure

Volumn 25, Issue 5, 2003, Pages 747-758

  Fialová, Lenka ^a   Zima, Tomáš ^a,b   Tesař, Vladimír ^a   Mikulíková, Ludmila ^b   Malbohan, Ivan M ^a   Merta, Miroslav ^a   Čertíková, Věra ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Anti 2 glycoprotein I; Antibodies to oxidized LDL; Antiphospholipid antibodies; Lupus nephritis

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN G; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; LIPOPROTEIN BLOOD LEVEL; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, LDL; LUPUS NEPHRITIS; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLINOSITOLS; PHOSPHATIDYLSERINES;

EID: 0141730373     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120024290     Document Type: Article

References (38)

1. Gharavi, A.E.; Harris, E.N.; Asherson, R.A.; Hughes, G.R.V. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann. Rheum. Dis. 1987, 46, 1-6.
2. Falcon, C.R.; Hoffer, A.M.; Carreras, L.O. Antiphosphatidylinositol antibodies as markers of the antiphospholipid syndrome. Thromb. Haemost. 1990, 63, 321-322.
3. Berard, M.; Chantome, R.; Marcelli, A.; Boffa, M.C. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases. J. Rheumatol. 1996, 23, 1369-1374.
4. Branch, D.W.; Silver, R.; Pierangeli, S.; van Leeuwen, I.; Harris, E.N. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstet. Gynecol. 1997, 89, 549-555.
5. Harris, E.N.; Pierangeli, S.S.; Gharavi, A.E. Diagnosis of the antiphospholipid syndrome: a proposal for use of laboratory tests. Lupus 1998, 7 (suppl 2), 144-148.
6. Cabral, A.R.; Cabiedes, J.; Alacron-Segovia, D. Hemolytic anemia related to an IgM autoantibody to phosphatidylcholine that binds in vitro to stored and to bromelain-treated human erythrocytes. J. Autoimmun. 1990, 3, 773-787.
7. 2-glycoprotein I in the absence of phospholipid: importance of antigen density and bivalent binding. J. Immunol. 1995, 154, 954-960.
8. Bevers, E.M.; Galli, M.; Barbui, T.; Comfurius, P.; Zwaal, R.F. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb. Hemost. 1991, 66, 629-632.
9. 2GPI in the antiphospholipid (Hughes') syndrome-from a cofactor to an autoantigen-from induction to prevention of antiphospholipid syndrome. Lupus 1998, 7, 503-506.
10. 2-Glycoprotein I: target antigen for antiphospholipid antibodies. Immunological and molecular aspects. Lupus 1998, 7 (suppl 2), S5-S9.
11. Schousboe, I. Beta-2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 1985, 66, 1086-1091.
12. 2-glycoprotein I. Biochim. Biophys. Acta 1986, 884 (1), 142-149.
13. 2-Glycoprotein I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis 1987, 63, 109-114.
14. 2-Glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulants. Blood 1993, 81, 1255-1262.
15. 2-glycoprotein I in autoantibody-mediated pregnancy loss (review). J. Reprod. Immunol. 1997, 36, 123-142.
16. 2GPI) binding to phospholipid (PL) membranes. Lupus 1996, 5, 522.
17. 2-glycoprotein I-dependent manner. J. Immunol. 1996, 157, 2201-2208.
18. Matsuura, E.; Igarashi, Y.; Fujimoto, M.; Ichikawa, K.; Koike, T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990, 336, 177-178.
19. Vaarala, O.; Puurunen, M.; Lukka, M.; Alfthan, G.; Leirisalo-Repo, M.; Aho, K.; Palosuo, T. Affinity-purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low-density lipoprotein. Clin. Exp. Immunol. 1996, 104 (2), 269-274.
20. 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages. Clin. Exp. Immunol. 1997, 107 (3), 569-673.
21. 2-glycoprotein I (and other proteins). Proc. Natl. Acad. Sci. USA 1997, 94, 10356-10361.
22. Harris, E.N. Antiphospholipid antibodies. Br. J. Hematol. 1990, 74, 1-9.
23. Hughes, G.R. Hughes' syndrome: the antiphospholipid syndrome. A historical view. Lupus 1998, 7 (suppl 2), S1-S4.
24. Piette, J.C. Towards improved criteria for the antiphospholipid syndrome. Lupus 1998, 7 (suppl 2), S149-S157.
25. Fialová, L.; Mikulíková, L.; Malbohan, I.M.; Benešová, O.; Zwinger, A. Prevalence of various antiphospholipid antibodies in pregnant women. Physiol. Res. 2000, 49, 299-305.
26. Zima, T.; Fialová, L.; Mikuliková, L.; Malbohan, I.M.; Popov, P.; Nešpor, K. Antibodies against phospholipids and oxidized LDL in alcoholic patients. Physiol. Res. 1998, 47, 351-355.
27. McNeil, H.P.; Chesterman, C.N.; Krilis, S.A. Immunology and clinical importance of anticardiolipin antibodies. Adv. Immunol. 1991, 49, 193-280.
28. Bevers, E.; Comfrius, P.; van Rijn, J.; Hemker, C.; Zwaal, R. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur. J. Biochem. 1982, 122, 429-436.
29. 2-glycoprotein I contains a phospholipid binding site (Cys 281-Cys 288) and a region recognized by anticardiolipin antibodies. J. Immunol. 1994, 52, 653-659.
30. 2-Glycoprotein I bound to oxidatively modified lipoproteins could be targeted by anticardiolipin antibodies. Lupus 1994, 3, 314-317.
31. Hörkkö, S.; Miller, E.; Dudl, E.; Reaven, R.V.; Curtiss L.K.; Zvaifler, N.; Terkeltaub, R.; Pierangeli, S.S.; Branch, D.W.; Palinski, W.; Witztum, J.L. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipid. J. Clin. Invest. 1996, 98 (3), 815-825.
32. Vaarala, O. Autoantibodies to modified LDLs and other phospholipid-protein complexes as markers of cardiovascular diseases. J. Inter. Med. 2000, 24, 381-384.
33. Urowitz, M.B.; Gladman, D.D. Accelerated atheroma in lupus-background (review). Lupus 2000, 9, 161-165.
34. Iuliano, L.; Pratico, D.; Ferro, D.; Pittoni, V.; Valesini, G.; Lawson, J.; FitzGerald, G.A.; Violi, F. Enhanced lipid peroxidation in patients positive for antiphosholipid antibodies. Blood 1997, 90, 3931-3935.
35. George, J.; Afek, A.; Gilburd, B.; Levy, Y.; Blank, M.; Kopolovic, J.; Harats, D.; Shoenfeld, Y. Atherosclerosis in LDL receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. Lupus 1997, 6 (9), 723-729.
36. Shoenfeld, Y.; Harats, D.; George, J. Atheroslerosis and the antiphospholipid syndrome. A link unravelled. Lupus 1998, 7 (suppl 2), S140-S143.
37. 2-glycoprotein I antibodies with lupus type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am. J. Med. 1992, 93, 181-186.
38. 2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein. Br. J. Rheumatol. 1998, 37, 883-888.